
William A. Craigo
Examiner (ID: 17649, Phone: (571)270-1347 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 936 |
| Issued Applications | 383 |
| Pending Applications | 126 |
| Abandoned Applications | 445 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16525229
[patent_doc_number] => 20200399309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS
[patent_app_type] => utility
[patent_app_number] => 17/010773
[patent_app_country] => US
[patent_app_date] => 2020-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27603
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17010773
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/010773 | THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS | Sep 1, 2020 | Abandoned |
Array
(
[id] => 16718449
[patent_doc_number] => 20210085596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => COMPOSITIONS FOR ORAL MUCOADHESIVE DOSAGE FORMS
[patent_app_type] => utility
[patent_app_number] => 16/996889
[patent_app_country] => US
[patent_app_date] => 2020-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16996889
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/996889 | COMPOSITIONS FOR ORAL MUCOADHESIVE DOSAGE FORMS | Aug 17, 2020 | Abandoned |
| 16/984340 | THYROID HORMONE ORAL DOSAGE FORMS AND METHODS OF USING THE SAME | Aug 3, 2020 | Abandoned |
Array
(
[id] => 16420740
[patent_doc_number] => 20200345938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => HYDROGEN PEROXIDE SOLUTION-PREFILLED SYRINGE WITH EXCELLENT HYDROGEN PEROXIDE PRESERVATION DUE TO SILICONE OIL INCLUDED IN OIL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/936199
[patent_app_country] => US
[patent_app_date] => 2020-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16936199
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/936199 | Hydrogen peroxide solution-prefilled syringe with excellent hydrogen peroxide preservation due to silicone oil included in oil composition | Jul 21, 2020 | Issued |
Array
(
[id] => 16420702
[patent_doc_number] => 20200345900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => ABSORBABLE PERMEABILITY-MODULATED BARRIER COMPOSITES AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/931552
[patent_app_country] => US
[patent_app_date] => 2020-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5298
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16931552
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/931552 | Absorbable permeability-modulated barrier composites and applications thereof | Jul 16, 2020 | Issued |
Array
(
[id] => 16620081
[patent_doc_number] => 20210038734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 16/928739
[patent_app_country] => US
[patent_app_date] => 2020-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19081
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 299
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16928739
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/928739 | MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES | Jul 13, 2020 | Abandoned |
Array
(
[id] => 17850645
[patent_doc_number] => 20220280686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => BONE REGENERATIVE AGENT AND METHOD OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/628313
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3731
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628313
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/628313 | BONE REGENERATIVE AGENT AND METHOD OF USING SAME | Jul 9, 2020 | Pending |
Array
(
[id] => 20451830
[patent_doc_number] => 12514873
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-06
[patent_title] => Stable pharmaceutical articles containing dilute povidone iodine formulations
[patent_app_type] => utility
[patent_app_number] => 16/962212
[patent_app_country] => US
[patent_app_date] => 2020-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 1266
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16962212
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/962212 | Stable pharmaceutical articles containing dilute povidone iodine formulations | Jul 7, 2020 | Issued |
Array
(
[id] => 18003354
[patent_doc_number] => 20220362120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => STABILIZATION OF RESORCINOL COMPOUNDS IN COSMETIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/623394
[patent_app_country] => US
[patent_app_date] => 2020-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17623394
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/623394 | STABILIZATION OF RESORCINOL COMPOUNDS IN COSMETIC COMPOSITIONS | Jun 22, 2020 | Pending |
Array
(
[id] => 17827580
[patent_doc_number] => 20220264884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => SYNERGISTIC FUNGICIDE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/622379
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12800
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622379
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/622379 | SYNERGISTIC FUNGICIDE COMPOSITION | Jun 11, 2020 | Pending |
Array
(
[id] => 19290461
[patent_doc_number] => 12029800
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => Composite particles including anionic polymer and cationic polymer or peptide, and method for producing composite particles
[patent_app_type] => utility
[patent_app_number] => 16/886001
[patent_app_country] => US
[patent_app_date] => 2020-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 8851
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 263
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16886001
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/886001 | Composite particles including anionic polymer and cationic polymer or peptide, and method for producing composite particles | May 27, 2020 | Issued |
Array
(
[id] => 17702736
[patent_doc_number] => 20220202742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => DOSAGE FORMS FOR PREVENTING DRUG-FACILITATED ASSAULT
[patent_app_type] => utility
[patent_app_number] => 17/608215
[patent_app_country] => US
[patent_app_date] => 2020-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19578
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17608215
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/608215 | DOSAGE FORMS FOR PREVENTING DRUG-FACILITATED ASSAULT | May 6, 2020 | Abandoned |
Array
(
[id] => 16374984
[patent_doc_number] => 20200323826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => SUSTAINED-RELEASE PREPARATION COMPOSITION FOR ANIMALS
[patent_app_type] => utility
[patent_app_number] => 16/867773
[patent_app_country] => US
[patent_app_date] => 2020-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16867773
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/867773 | Zero-order release preparation composition for animals | May 5, 2020 | Issued |
Array
(
[id] => 18268708
[patent_doc_number] => 20230089950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => LITHIUM ION COMPOSITION AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/798547
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17798547
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/798547 | LITHIUM ION COMPOSITION AND APPLICATION THEREOF | Apr 27, 2020 | Pending |
Array
(
[id] => 16733812
[patent_doc_number] => 10959429
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-30
[patent_title] => Disinfectant formulation
[patent_app_type] => utility
[patent_app_number] => 16/835409
[patent_app_country] => US
[patent_app_date] => 2020-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8562
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16835409
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/835409 | Disinfectant formulation | Mar 30, 2020 | Issued |
Array
(
[id] => 16189218
[patent_doc_number] => 20200230067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => SUSPENSIONS OF ENCAPSULATED PHARMACEUTICALS AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/835715
[patent_app_country] => US
[patent_app_date] => 2020-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13269
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16835715
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/835715 | SUSPENSIONS OF ENCAPSULATED PHARMACEUTICALS AND METHODS OF MAKING AND USING THE SAME | Mar 30, 2020 | Abandoned |
Array
(
[id] => 16175114
[patent_doc_number] => 20200222082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => METHODS AND DEVICES FOR CONDUIT OCCLUSION
[patent_app_type] => utility
[patent_app_number] => 16/834716
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18388
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16834716
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/834716 | Methods and devices for conduit occlusion | Mar 29, 2020 | Issued |
Array
(
[id] => 16189448
[patent_doc_number] => 20200230297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => Drug Eluting Implant
[patent_app_type] => utility
[patent_app_number] => 16/826062
[patent_app_country] => US
[patent_app_date] => 2020-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16826062
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/826062 | Drug Eluting Implant | Mar 19, 2020 | Abandoned |
Array
(
[id] => 16153747
[patent_doc_number] => 20200215106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => TREATING ROTATOR CUFF CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 16/823019
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823019
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823019 | Treating rotator cuff conditions | Mar 17, 2020 | Issued |
Array
(
[id] => 17609617
[patent_doc_number] => 20220151896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => EFFICIENT SUNSCREEN COMPOSITIONS WITH DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE AND ORGANIC PARTICULATE UV FILTER
[patent_app_type] => utility
[patent_app_number] => 17/439581
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17439581
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/439581 | EFFICIENT SUNSCREEN COMPOSITIONS WITH DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE AND ORGANIC PARTICULATE UV FILTER | Mar 12, 2020 | Abandoned |